Cancer - Liver

The purpose of this study is to compare the effects, good or bad, of combination immunotherapy (atezolizumab plus bevacizumab) versus observation (not receiving any treatment) on participants with completely resected or ablated hepatocellular cancer (HCC) who are at high risk for disease recurrence. In this study, patients will receive either atezolizumab plus bevacizumab or no treatment.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4
Neurological Conditions (Other) - MND, Spinal Cord Injury, Stroke

An early feasibility study of the safety of the Stentrode™ device in participants with loss of motor function due to paralysis from spinal cord injury, motor neuron disease, stroke, muscular dystrophy or loss of limbs.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4
Dermatological Conditions

Hidradenitis suppurativa (HS) is a chronic inflammatory debilitating skin condition characterised by painful, deep skin lesions commonly under the arms or in the groin area. It can be treated with topical treatments on the skin, tablets, injections or infusions.

The investigational drug for this study is called bimkizumab and is given as an injection into the skin.

The purpose of this research project is to measure how safe and effective this medication is in treating participants with HS. Prior research studies in humans have shown that this medication may help control the immune system that is responsible for the signs and symptoms of HS and help achieve disease improvement.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4
Mental Health

Bipolar Disorder and Schizophrenia Spectrum Disorders impact not only the person who has the illness but also the lives of family members and friends who help support them.

By completing an online survey, you will be contributing to a better understanding of caregiver experiences. This information will be particularly helpful for working out ways to better support caregivers. The questions will ask you to reflect on your experience and thoughts about caregiving and how you have been going in different areas of your life with regard to your health, work, relationships, beliefs, and wellbeing.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4
Dermatological Conditions

Pemphigus is a rare, autoimmune skin condition characterised by blistering and itchiness. Many patients who have pemphigus require treatment with topical steroids, tablets, injections or infusions.

The purpose of this research project is to measure how safe and effective efgartigimod is in treating participants with pemphigus also receiving oral corticosteroids. Efgartigimod is injected into the skin.

Prior research studies in humans have shown that efgartigimod may help control the immune system that is responsible for the signs and symptoms of pemphigus and help achieve disease improvement.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4
Dermatological Conditions

Generalised pustular psoriasis is a rare skin disorder that presents with flares of widespread pustules on a background of red and tender skin. It can be treated with special creams for the skin, tablets or injections.

The investigational drug for this study is called spesolimab and is given as an injection into the skin.

The purpose of this research project is to measure how safe and effective this medication is in treating participants with generalised pustular psoriasis. Prior research studies in humans have shown that this medication may help control the immune system that is responsible for the signs and symptoms of generalised pustular psoriasis and help achieve disease improvement.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4
Dermatological Conditions

Hidradeninitis Suppurativa is a chronic inflammatory debilitating skin condition characterised by painful, deep skin lesions commonly under the arms or in the groin area. It can be treated with topical treatments on the skin, tablets, injections or infusions.

The investigational drug is given as an injection into the skin and targets one part of the pathway involved in HS.

The purpose of this research project is to measure how safe and effective this medication is in treating participants with hidradenitis suppurativa. Prior research studies in humans have shown that this medication may help control the immune system that is responsible for the signs and symptoms of hidradenitis suppurativa and help achieve disease improvement.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4
Dermatological Conditions

Hidradeninitis Suppurativa (HS) is a chronic inflammatory debilitating skin condition characterised by painful, deep skin lesions commonly under the arms or in the groin area. It can be treated with topical treatments on the skin, tablets, injections or infusions.

The investigational drug for this study is called spesolimab and given as an injection into the skin.

The purpose of this research project is to measure how safe and effective this medication is in treating participants with HS. Prior research studies in humans have shown that this medication may help control the immune system that is responsible for the signs and symptoms of HS and help achieve disease improvement.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4